Can Water Professionals Transform Pharmaceutical Disposal Practices of Hospice Nurses? by McCoy, Jennifer L. & Holland, Kimberly P.
Kennesaw State University
DigitalCommons@Kennesaw State University
Dissertations, Theses and Capstone Projects
4-1-2011
Can Water Professionals Transform Pharmaceutical





Follow this and additional works at: http://digitalcommons.kennesaw.edu/etd
Part of the Environmental Policy Commons, Environmental Public Health Commons, Health
Policy Commons, Nursing Commons, Public Administration Commons, and the Public Policy
Commons
This Thesis is brought to you for free and open access by DigitalCommons@Kennesaw State University. It has been accepted for inclusion in
Dissertations, Theses and Capstone Projects by an authorized administrator of DigitalCommons@Kennesaw State University.
Recommended Citation
McCoy, Jennifer L. and Holland, Kimberly P., "Can Water Professionals Transform Pharmaceutical Disposal Practices of Hospice
Nurses?" (2011). Dissertations, Theses and Capstone Projects. Paper 449.
 
Changing Behavior:  





Jennifer L. McCoy and Kimberly P. Holland 
 
 
A Practicum Paper  





















            
 
Changing Behavior: 




This project is an explanatory case study that illustrates the problems associated with 
pharmaceutical disposal in regard to water quality.  The purpose of the study is to investigate the 
current pharmaceutical disposal practices of hospice nurses, the attitudes of hospice nurses 
regarding current pharmaceutical disposal practices, and explore ways to educate the hospice 
community about the concerns associated with flushing pharmaceuticals.  The study consisted of 
reviewing secondary research, completing a survey, forming a focus group, implementing a pilot 
study, and developing an education plan and outreach materials.   
The researchers partnered with two local nonprofit organizations, Georgia Association of 
Water Professionals (GAWP) and Georgia Hospice and Palliative Care Organization (GHPCO), 
in developing this project.  GAWP sponsored participant incentives, provided meeting space, and 
endorsed the project deliverables.  GHPCO facilitated the distribution of the survey to member 
organizations, assisted with the recruitment of focus group members, and provided feedback and 
guidance throughout the entire project.  Our findings indicated that hospice providers are 
concerned about medication disposal practices and the potential harm hospice may be doing 
through current medication disposal methods.  We also found that most nurses were receptive to 
changing current procedures.  However, changing the existing policy does have some challenges.  This 
study explores the issues facing both the hospice industry and the water industry in addressing 
the practice of flushing medications as a method for pharmaceutical disposal.  Finally, it examines the 
utilization of tools such as advanced water treatment processes, legislation, and education to 
reduce the impact of this form of “nonpoint source pollution” in our water resources. 
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Pharmaceuticals and Personal Care Products (PPCPs) are a major concern and an 
emerging issue for professionals in the water and wastewater industry.  Standard drinking water 
and wastewater treatment techniques are not designed to remove complex chemicals found in 
PPCPs from drinking water or wastewater.  Pharmaceutical compounds that pass through the 
treatment process provide a mechanism for exposure to consumers and the environment.  The 
elimination of source pathways in which pharmaceuticals enter water sources is an immediate 
measure to reduce the volume of PPCPs as pollutants.  One such pathway is the disposal of 
medicines in the residential setting.  In recent years, community outreach programs have been 
implemented on local levels to begin counteracting the issue of improper drug disposal.  In 
addition to the typical resident, it has been learned that many hospice providers utilize flushing 
as a primary means of pharmaceutical disposal.  As professionals in the water industry, we 
would like to address this practice and develop alternative best management practices (BMPs) 
for the disposal of pharmaceuticals by hospice providers. 
The issue of water quality is relevant to every living organism on earth. It is of all 
resources, the most fundamental to survival. Water quality and quantity is taken for granted in 
much of the developed world because of the disinfection technology, affordability, and 
accessibility developed countries enjoy.  Specifically, the United States is a nation privileged to 
have, “one of the cleanest drinking water supplies in the world” (U.S. Environmental Protection 
Agency 2003).  Every morning, Americans can prepare meals, bathe, and drink straight from the 
tap without a second thought about the safety of the product they are consuming.  Perhaps, it 
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would be shocking for many Americans and Westerners alike to know that globally there are 1.1 
billion people who live without access to safe drinking water (Smolan and Erwitt 2007, 7).  It is 
even more staggering to consider that each year 1.8 million children die from waterborne 
illnesses worldwide (Smolan and Erwitt 2007, 11).  Elsewhere on the planet, people spend much 
of their day hauling water for daily use.  This water is often contaminanted as a result of poor 
sanitation practices  (Smolan and Erwitt 2007, 13).  In developing countries, many water sources 
carry diseases such as cholera and typhoid; diseases that have been eradicated in the United 
States by the disinfection of drinking water. 
By having the benefit of fundamental water treatment processes here in the United States, 
there is now a need to examine the impact of other emerging contaminants which may pose long 
term health concerns.  Safe drinking water is a direct result of conventional water and wastewater 
disinfection techniques.  However, there is now a concern that prolonged exposure from 
reminent contaminents such as PPCPs could pose health risks to humans and wildlife.  The term 
“microconstituent” is used to describe compounds detected in the environment which may 
impact the health and development of living organisms (Virginia Department of Environmental 
Quality 2011).  Microconstituents can be naturally occurring or man-made (Virginia Department 
of Environmental Quality 2011).  PPCPs are classified as a type of microconstituents and may be 
described as such in this paper. Extensive studies are now being published documenting potential 
problems associated with exposure to microconstituents, including physical mutations in aquatic 
life (Hoffbuhr 2009; Ortner and McCullagh 2010; Virginia Department of Environmental 
Quality 2011).  These studies call attention to the emerging issue of microconstituents and the 
need to pursue further research and funding regarding risk assessment, treatment processes, and 
regulatory controls. 
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The purpose of this project is to provide public awareness of microconstituents, 
specifically pharmaceuticals, as a “non-point source” of water pollution and introduce reduction 
measures.  Within this research, reduction in pharmaceutical compounds entering water sources 
will be concentrated primarily to hospice providers to frame a manageable scope.   
 
Public Values in Conflict 
When considering the issue of pharmaceuticals in water, the hospice industry and the 
water industry emphasize different priorities to accomplish their service mission.  Although both 
industries work towards ensuring public health, each also have a separate avenue to achieve their 
purpose.  Hospice, utilizes medicine as a means to support the health of the general population.  
On the other hand, the water industry uses the protection of the environment as the instrument to 
support the health of the general population.  Using different methods to accomplish the same 
goal can cause tension between interest groups. 
The primary function of the water industry is to provide water and wastewater treatment, 
water distribution, wastewater collection, and storm water collection.  Although the water 
industry is comprised primarily of municipal government utilities, it also includes consultants, 
contractors, manufacturers, and regulators.  All these sectors of the industry work in tandem to 
provide water and wastewater service to consumers.  Many also participate in industry specific 
professional organizations, the largest in the state being the Georgia Association of Water 
Professionals (GAWP).  The mission of GAWP is to promote education, legislation, and “sound 
principles” as related to water resources, utilization, and protection thereof, which are exercised 
through industry professionals and the general public (Georgia Association of Water 
Professionals 2010).  With a membership of over 4,000 water professionals, the GAWP is a 
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strong network of knowledge and sound communication group in the water industry.  The 
authors deployed the resources available through GAWP for this research. 
Similarly, the hospice industry has a state-wide organization called the Georgia Hospice 
and Palliative Care Organization (GHPCO).  The GHPCO brings together hospice providers 
from across the state to “provide information, education, and advocacy” for members and people 
across the state who are interested in hospice medical care (Georgia Hospice and Palliative Care 
Organization 2009).  Hospice is a type of medical care for those who are in the final stages of 
their lives as a result of terminal illness or chronic disease, when treatment is discontinued and 
the comfort of the patient becomes the primary goal (Hospice Foundation of America 2011). 
This care is characteristically available when a patient is expected to live less than six months 
(Hospice Foundation of America 2011).  It is a concept that has become more prevalent since its 
inception in the early 1970s, most likely a result of extended life expectancy from advances in 
medicine (Hospice Foundation of America 2011).  Hospice services, which are often covered 
under Medicare and other health insurance, can be provided at an in-care facility or in the 
patient’s home.  When provided in the home, hospice care includes counseling, encouragement 
services, and medical care (Hospice Foundation of America 2011).  The medical aspect of 
hospice care is performed by registered nurses who help the patient and family with a variety of 
tasks such as pain management, bathing, administration of medications, and general guidance 
through the end of life process.  When a patient passes away, the hospice nurse helps the family 
with necessary arrangements including transport of the patient’s remains, removal of medical 
equipment, and the disposal of medications.   
The nature of service that hospice specializes in is a delicate work.  End-of-life as related 
specifically to the hospice care is a result of extended illness in which patients and their families 
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have endured physical and emotional suffering.  Needless to say, it is a very difficult and 
stressful environment for hospice caregivers and the families they are assisting, especially upon 
the death of the patient.  It is at this point that hospice nurses must manage many issues for the 
family, posthumously.  One such issue is the disposal of medications administered to the patient 
during hospice care.     
Patients under hospice care are often prescribed the most powerful medications available, 
making the safe disposal of these pharmaceuticals imperative.  Prevention of accidental 
poisoning from pharmaceutical disposal is a concern for children and pets in the home and 
wildlife outside of the home.  There is also concern about the diversion, which is the deliberate 
use of prescription medication by a person other than the patient it was prescribed to (Spartz and 
Shaw 2009, 19). Federal agencies now discourage flushing as a means of pharmaceutical 
disposal.  However, the Food and Drug Administration (FDA), having authority over drug 
distribution, continues to recommend the flushing disposal method for a short list of specific 
pharmaceuticals (Food and Drug Administration 2010).  These pharmaceuticals are comprised 
primarily of narcotic analgesics, including morphine and oxycotin in various forms (Food and 
Drug Administration 2010).  In response to the gravity of the situation, the authors of this 
research presume that hospice nurses are disposing of the deceased’s pharmaceuticals in the 
quickest and cleanest way possible in order to reduce any stress or endangerment for the family.   
Professionals in any industry learn about their subject matter through education and 
experiential knowledge.  This requires both time and interest on the part of the individual.  
Therefore, it is unreasonable to assume that people in the field of medicine, specifically hospice, 
associate behavior such as flushing medication with the resulting condition of polluted surface 
water.  Most people outside the water industry do not know about, and are not interested in, the 
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removal of containments from wastewater.  Moreover, for years, government agencies have 
promoted flushing as the most appropriate means of disposal (Ortner and McCullgah 2010, 15).  
Even today, the FDA continues to recommend flushing as the preferred method of some specific 
medications  (Food and Drug Administration 2010).  This recommendation seems to be an easy 
and effective way to remove the danger of pharmaceuticals from residential and commercial 
settings  (Ortner and McCullgah 2010, 16).   Therefore, it is logical that hospice organizations 
would practice this method of disposal.  
Through the collaboration of the hospice and water industries, the ultimate goal for this 
project is to develop proactive alternatives for PPCP disposal and reinforce proper stewardship 
of our natural resources.  The authors feel that a protocol can be put in place for hospice 
providers that would be simple, inexpensive, and safe for all parties involved.  We hope to 
develop feasible protocols that can be implemented without adding additional financial or labor 
burdens to local hospice providers.  These protocols will be shared with water and wastewater 





Pathways of Pollution 
 
Wastewater effluent discharges are the largest contributor of pharmaceuticals in water 
sources (Snyder et al 2008, 10).  However, it is important to remember that pharmacological 
compounds found in wastewater effluents originate from many sources.  The most prevalent 
introduction of drugs to wastewater comes from the waste excretion by the drug consumer 
(Rodriguez-Mozaz and Weinberg 2010, 1016).   The degree to which a pharmaceutical is 
metabolized by the human body is somewhat dependent upon the individual’s overall health, 
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food intake, body composition, and age (Daughton 2007, 12).  Additionally, the chemical 
structure of pharmaceuticals are wide-ranging, so different drugs will be metabolized and 
absorbed at differing rates.  Therefore, they are also excreted at varied concentrations  (Daughton 
2007, 12).  Analygesics, antibiotics, beta-blockers, lipid regulators, and hormones are classes of 
pharmaceutical compounds frequently detected in wastewater effluents  (Snyder et al 2008, 68).   
The consumption and subsequent excretion of these classes of compounds makeup the foremost 
entryway for pharmaceuticals into wastewater effluents (Daughton 2007, 12) .   
Another contamination pathway for pharmaceuticals in wastewater effluents come from 
the disposal of medication (Daughton 2007, 13).  Disposal pathways originate from consumers, 
health care facilities, and professionals that administer pharmaceuticals that use flushing as a 
disposal method for unused drugs (Snyder et al 2008, 10).  Again for years, it was considered 
best practices to use flushing as the disposal method for unused medications (Ortner and 
McCullagh 2010, 15).  Imagine the volume of unused and expired medications held by hospitals, 
pharmacies, nursing homes, and doctors’ offices. The Associated Press released data in 2008 that 
estimated over 250 million pounds of pharmaceutical waste were discarded by health care 
facilities (Hoffbuhr 2009, 15).  It is unknown what percentage of this waste is flushed  (Hoffbuhr 
2009, 15).  Then consider the typical household which has cabinet full of over-the-counter and 
prescription drugs (Spartz and Shaw 2009).  Over-the-counter and prescription medications are 
more readily available and affordable today than ever before.  In 2007 alone, more than 7 billion 
units of prescription and over-the-counter drugs were sold (Hoffbuhr 2009,  15).   
Finally, industrial discharges and runoff also contribute to pharmaceuticals in water 
sources, albeit to a lesser degree (Snyder et al 2008, 10).  Though not as significant in this 
research, it is interesting to note that industrial manufacturing waste can contain pharmaceuticals, 
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depending on the product they are manufacturing.  Additionally, waste streams from agriculture, 
specifically livestock farming contribute to pharmaceutical contaminants in runoff and find their 
way to water sources (Hoffbuhr 2009, 17).  
 
Emergence of the Issue 
 With the emergence of water issues as a principal environmental concern for the global 
community, it is evident that water is the most essential resource on the planet.  There have been 
disputes over water rights throughout history and these issues continue today.  As water becomes 
a sparse resource, people become more concerned with the quantity and quality of water 
available for consumption.  Population growth, exponential rises in pharmaceutical consumption, 
and broader understanding of environmental issues have prompted concern that the flushing 
disposal method may have an unforseen impact on human and ecological health  (Hoffbuhr 
2009, 12).   
Over the past forty years, various substances have been identified in water sources, 
including pharmaceutical compounds (Snyder et al 2008).  As monitoring technology becomes 
more sophisticated than ever before, it is commonplace to find traceable concentrations of 
pharmaceuticals in raw water sources, treated drinking water, wastewater, and wastewater 
effluent (Ragain 2009).  There have been tremendous advances in detection technology in the 
last few decades   (Snyder 2008).  Years ago, scientists could detect compounds at levels of 
parts-per-million; it is now common practice to utilize detection levels of parts-per-billion with 
more sensitive levels on the horizon (Snyder 2008, 2).  Identifying trace microconstituents have 
raised concerns about water quality regarding the safety of consumption as well as 
environmental impact (Hoffbuhr 2009, 4).   However, as Shane Snyder from the Southern 
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Nevada Water Authority points out, the detectability of minuscule concentrations of a 
microconstituent does not mean that it is harmful (Snyder 2008, 2).  He reports that “the highest 
concentration of pharmaceutical level we detected in U.S. drinking water is approximately 
5,000,000 times lower than the therapuetic dose”  (Snyder 2008, 2). Since these tiny traces are 
difficult to comphrehend, Synder (2008) provides an analogy that this concentration level is 
equivalent to “one second in approximately 750 years” (2008, 2).  Nonetheless, the effects of 
long term exposure to these pharmaceuticals is currently unknown  (Snyder 2008). 
 In the United States, municipal drinking water must meet stringent standards which are 
set and enforced by the United States Environmental Protection Agency (USEPA) under the 
delegation of the Safe Drinking Water Act and the Clean Water Act (Hoffbuhr 2009, 8).  For 
decades the USEPA has mandated that utilities perform comprehensive drinking water and 
source water monitoring.  Utilities are currently required to monitor for 90 different 
contaminants that fall below the maximum contaminant level (MCL) for each one (Hoffbuhr 
2009, 8).  Many utilities test more extensively than what is mandated, however any contaminant 
that is found must be reported on the annual Water Quality Report distributed by the system.  
Additionally, the USEPA’s list of regulated contaminants is dynamic because the Safe Drinking 
Water Act requires that a new list of potential contaminants be evaluated every five years, called 
the Contaminant Candidate List (Hoffbuhr 2009, 8).  Substances on the Contmainant Candidate 
List will be scrutinized to determine if they should be added to the regulated contaminants under 
the Safe Drinking Water Act.    
Likewise, the USEPA regulates contaminants released in wastewater effluents (Hoffbuhr 
2009, 10).  Wastewater effluent is the treated wastewater discharged from the treatment facility 
to surface water.  The effluent is diluted with surface water and typically becomes a water supply 
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source for downstream populations.  Although the significance of exposure to humans is still 
inconclusive, there is evidence that exposure to certain microconstituents found in waterways 
have a detrimental impact on aquatic wildlife (Hoffbuhr 2009, 22; Hunter et al 2008).  While 
many questions remain unanswered regarding this issue, the uncertainty of this topic has caused 
an increased concern for water utilities in the provision of safe drinking water and protection of 
environmental health.   
 
Impact of Microconstituents 
 
 Although it is generally accepted that there are microconstituents in water sources, 
questions remain concerning the overall health risks associated with these contaminants 
(Pritchard 2008; Pontius 2008).  The long term health effects of chronic exposure to trace 
concentration of microconstituents are unknown (Snyder et al 2008, 123).  Research has 
indicated that there is a link between microconstituent exposure and the endocrine mutations of 
some aquatic species (Virginia Department of Environmental Quality 2011; Hunter et al 2008).  
Fish and amphibians are continually exposed to traces of microconstituents throughout their 
entire life (Ruhoy and Kaye 2009-2010, 27).  Reported effects include “dysfunctional growth 
and development, altered neurological physiology, and impaired mating and gender assignment” 
(Ruhoy and Kaye 2009-2010, 27). Many microconstituents are thought to disrupt the endocrine 
systems which regulate hormones in the body (Hoffbuhr 2009, 21).  Reproduction, physical 
development, and behavior are elements which are managed by the endocrine system (Hoffbuhr 
2009, 22).  Therefore, chronic exposure to endocrine disrupting compounds (EDCs), like 
pharmaceuticals, could have disastrous effects on aquatic wildlife populations. 
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 Humans are exposed to microconstituents in differing environments than aquatic wildlife.  
Although consuming water may expose humans to trace doses of microconstituents, one study 
reveals that a person could drink 50,000 eight-ounce glasses of water per day containing the 
highest levels of microconstituents ever detected and not experience any negative health effects 
(Hoffbuhr 2009, 21).  It is also essential to remember that humans have pervasive exposure to 
microconstituents through just about every product we consume from meat and produce to 
personal care products and product packaging (Virginia Department of Environmental Quality 
2011). 
 Currently, the overall effects of long term exposure to microconstituents are inconclusive.   
However, Ruhoy and Kaye (2009-2010, 27-28) discuss the complexity of this issue thusly: 
Health effects of any environmental contaminant are difficult to ascertain because 
people are exposed to multiple toxins over decades.  Humans are not exposed to a 
single chemical or a single class of chemical.  Rather, we are exposed to multiple 
combinations of environmental pollutants that may vary at different geographic 
locations.  Not only to the pollutants to which we are exposed vary over a lifetime, 
but their effect will be different at different points in our development (fetus, 
neonate, adolescent, older adult). 
On the basis of the foregoing discussion, the concern of microconstituents is multifaceted.  Not 
only must researchers examine exposure, but specifically the type of exposure, point in the 
organism’s development, and the combination of microconstituents and their potential by-
products (Ruhoy and Kaye 2009-2010). 
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The Economy and Effectiveness of the Man-Made Water Cycle 
Conventional water and wastewater treatment methods are primarily designed for 
biological disinfection and do not target removal of complex microconstituents (Rodriguez-
Mozaz and Weinberg 2010, 1017; USEPA 2010c, 2).   The treatment of drinking water is carried 
out in a succession of stages.  Water is taken from a water source, for example, a river and is 
transported to a treatment facility.  The first stage of treatment for drinking water is the 
flocculation/sedimentation stage which attracts particles and causes them to settle to the bottom 
of the tank (U.S. Enironmental Protection Agency 2010c; U.S. Environmental Protection Agency 
2010d).  In the second stage, the water goes through the filtration process which captures and 
removes smaller particles (U.S. Environmental Protection Agency 2010d).  This is followed by 
the third stage, the disinfection process, which uses chlorine, chloramines, or chlorine dioxide to 
kill microscopic organisms (U.S. Environmental Protection Agency 2010d).  Throughout the 
three stages, the water is monitored for quality assurance.  After it completes the treatment 
process, the clean drinking water is distributed by utilities through a network of water pipes to 
reach consumers. 
After the consumer has used the water, it then becomes classified as wastewater.  If the 
consumer is on a public sewer system, the wastewater is collected by wastewater mains and 
transported to the wastewater treatment facility.  The premise behind wastewater treatment was 
to sanitize dirty water so that it may be reintroduced into water sources for reuse.  While many 
utilities have variations in treatment techniques, there is a conventional process practiced by 
most in the industry.  The first steps in the treatment process are preliminary and primary stages 
which removes solids from the wastewater (Water Environment Federation 2009).  Then 
secondary treatment step breaks down organic matter (Water Environment Federation 2009).    
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During the final stage, advanced treatment, nutrients are removed from the water, followed by 
disinfection using chlorine, ultraviolet light or ozone (Water Environment Federation 2009).    
After this entire process, the effluent is discharged back into source water, where it becomes 
diluted with the source water and will likely be treated and used by those who live downstream 
(Water Environment Federation 2009; USEPA 2010c, 2).   The “man-made water cycle” or 
“water use cycle” as it is referred to, is an invaluable part of modern life.   
 
Advanced Treatment Processes 
There are several advanced treatment processes that can be added to supplement the 
conventional treatment process, however, there are cost and environmental impacts that would 
coincide with the implementation of these additional treatment methods.   Each advanced process 
may be effective in the further reduction of microconstituents, with efficiencies dependent upon 
the specific conditions of treatment, specifically the type of water and contaminants being 
processed (USEPA 2010b, 25).  The following describes a few of the advanced treatment 
methods that can be added to supplement the conventional treatment process, all of which can be 
used in water and/or wastewater treatment facilities. 
Granular Activated Carbon: Granular activated carbon (GAC) is an adsorption process used in 
the form of “filter media” (AWWA Organic Contaminants Control Committee 2008, 20).  The 
GAC media has a limited life span of a period of months up to a decade depending upon the type 
of water passing through, type of and exposure to microconstituents, and grade of GAC media 
(AWWA Organic Contaminants Control Committee 2008, 20).   
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Ozone Disinfection: Ozone is a robust oxidant and disinfectant process used for the effective 
removal of microconstituents (AWWA Organic Contaminants Control Committee 2008, 21).  
There are however, environmental considerations when using ozone.  Surplus ozone must be 
properly disposed to avoid release into the environment.  Additionally, some treatment scenarios 
may propagate bromate, which is a disinfection by-product (AWWA Organic Contaminants 
Control Committee 2008, 21).   
Reverse Osmosis: Reverse osmosis (RO) is an intensive membrane filtration process that has 
been very successful in removing most microconstituents (AWWA Organic Contaminants 
Control Committee 2008, 21).    RO is a process that uses high pressure to push water through 
the membrane filter trapping even dissolved contaminants (USEPA 2010c, 25).  Arguably the 
most effective advanced treatment process, it is also the most expensive (Pritchard 2008).  
Furthermore, the residual contaminant removed by the RO process must be collected for proper 
disposal to ensure environmental protection (USEPA 2010c, 25). 
Under the Clean Water Act, the USEPA regulates wastewater discharge, requiring treated 
effluent to meet specific federal standards.  The quality of the effluent is constantly monitored by 
utilities at the treatment facility prior to releasing it back into a water source.  It is certainly 
possible to expand the parameters of the treatment processes to allow for the removal of 
microconstituents.  However, this type of infrastructural expansion will be quite costly and there 
is little substantial evidence to quantify these large scale system upgrades (Hoffbuhr 2009, 24-
25).   Research has indicated that some microconstituents do respond to traditional wastewater 
treatment processes (Emerging Contaminants Workgroup of the Santa Clara Basin Watershed 
Management Initiative 2005, 2).  Nevertheless, the Emerging Contaminants Workgroup from 
Santa Clara, California contend that the “removal efficiences of pharmaceuticals appear to be 
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chemical specific, especially since many synthetic compounds are designed to be resistent to 
biological degredation” (Emerging Contaminants Workgroup of the Santa Clara Basin 
Watershed Management Initiative 2005, 2).  The effective removal of such a broad spectrum of 
pharmaceutical compounds will require the addition of multiple processes in the advanced 
treatment stage  (Emerging Contaminants Workgroup of the Santa Clara Basin Watershed 
Management Initiative 2005,  2; AWWA Organic Contaminants Control Committee 2008, 20).   
Advanced treatment technologies can be used for microcroconstituent removal, however at this 
time, the cost-benefit to implement this type of infrastructure upgrade is unclear (Pontius 2008).  
More comprehensive research is required to adequately assess the need for advanced treatment 
processes since the impact of microconstituents and additional costs are not fully known. 
Since the effects of traceable microconstituents in drinking water are unclear, the USEPA 
has not set standards on any pharmaceutical compounds (Snyder et al 2003, 453).  It is simply not 
yet known if there are any negative effects from long term exposure of pharmaceuticals in small 
doses through drinking water (Daughton and Ternes 1999, 908).  Therefore, government 
agencies are suggesting that the most effective means of reducing the concentration of 
pharmaceuticals in water sources is the prevention of entry into wastewater systems (Daughton 
and Ternes 1999, 911).  This can be accomplished by a number of methods including take back 
programs, modification of drug distribution, and education regarding proper disposal techniques 
(Daughton and Ternes 1999, 911). 
Preventive measures for the reduction of pharmaceuticals in wastewater streams are the 
most preferred mechanisms and can be approached in several ways.  For example, 
pharmaceutical collection events through local utilities (Herring et al 2008, 341) and 
pharmaceutical mail-back programs (Ruhoy and Kaye 2009-2010, 28) have been successful in 
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many communities. Perhaps most importantly, a standardized procedure should be developed to 
direct proper disposal of unused pharmaceuticals (Herring et al 2008, 341).  The broad 
dissemination of accurate information to the medical community and the general population is 
essential.  Through all these solutions, education is the key component.  It is crucial for the 
population to understand that the improper disposal of pharmaceuticals may have a negative 
impact on human and environmental health (Spartz and Shaw 2009, 22). 
 
Regulations for Health Care Providers  
 Currently drinking water and wastewater effluent standards do not include removal of 
microconstituents.  Because this issue is of an emerging nature, utilities are not regulated in 
relation to pharmaceutical compounds.  However, health care providers are required to meet state 
and federal guidelines regarding the disposal of unused pharmaceuticals (U.S. Environmental 
Protection Agency 2010b).  The dangers of poisoning and diversion have been primary drivers in 
the establishment of the federal regulations that are in place.  Some of the regulations hospice 
providers must abide by include: 
The Controlled Substances Act:  This law is overseen by the Drug Enforcement Agency.  The 
DEA “prohibits the return of controlled substances from end-users to DEA registrants” (U.S. 
Environmental Protection Agency 2010b, 9).  These registrants include pharmacies and medical 
staff.  Therefore, it is illegal for medical personnel, including hospice home-health care to take a 
controlled substance from a patient and dispose of it outside the home of the patient.  This may 
encourage hospice providers to use the practice of flushing to dispose of a patient’s unused 
pharmaceuticals (U.S. Environmental Protection Agency 2010b, 9). 
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The Resource Conservation and Recovery Act (RCRA):  The USEPA is the agency in which 
governs hazardous waste from the “cradle to the grave” (U.S. Environmental Protection Agency 
2010b, 10).  Some pharmaceuticals are classified as hazardous waste once they are discarded, so 
health care providers, including hospice must adhere to the RCRA in regards to the distribution, 
transportation, storage, and disposal of pharmaceuticals which fall within the hazardous waste 
category (U.S. Environmental Protection Agency 2010b, 10). 
The Centers for Medicare and Medicaid Services (CMS):  The Department of Health and Human 
Services oversees the Medicare program. Requirements for activities performed under the 
provision of Medicare must comply with the rules administered through this act.  Since a large 
portion of hospice patients are covered under Medicare and therefore, hospice care is paid for by 
the Medicare program and their procedures must abide by the standards set with this legislation.  
Additionally, Medicaid which is partially funded with federal dollars but administered through 
each state is regulated through this act.  However, it gives the state the ability to manage certain 
aspects of pharmaceutical distribution and disposal through the state health departments and the 
state board of pharmacy (U.S. Environmental Protection Agency 2010b, 10). 
Safe Drug Disposal Act of 2010:  This legislation calls for the USEPA to study the impacts of 
pharmaceutical disposal.  As a result of this study, the USEPA will make an assessment of the 
environmental impact of pharmaceutical disposal; make recommendations on potential disposal 
programs, as well as the legal and cost ramifications of their proposals.  Furthermore, this act 
will give local agencies more leeway to operate pharmaceutical take-bake programs (Water 
Environment Federation 2010).   
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Care Provided by Hospice 
One of the most difficult aspects of medical care is performed by Hospice.  Hospice 
provides medical care for patients who are in their final stages of life as a result of terminal 
illness or those who must manage chronic disease (Hale 2010).  Because of the function they 
provide in patient care, they must administer and ensure proper disposal of pharmaceuticals in a 
residential setting (Becker, Ortner and Tuallai-McGuinness 2010, 203). “The role of long-term 
care facilities and hospice may contribute substantially to pharmaceutical waste because of 
polypharmacy and frequent changes in patient medications as a result of multiple, degenerative 
conditions” (Becker, Ortner and Tuallai-McGuinness 2010, 203).  After years of directives to 
flush unused pharmaceuticals, environmental concerns are calling for the change of that standard 
procedure (Ortner and McCullagh 2010, 15; U.S. Environmental Protection Agency 2010b).   
The Georgia Hospice and Palliative Care Organization (GHPCO) graciously provided 
their support for this research project on pharmaceutical disposal methods.  For the purposes of 
this project, a survey was distributed to the members of GHPCO to determine the perspective of 
hospice providers in the State of Georgia.  Using the results of the survey, a focus group of water 
and hospice professionals developed a contemporary, standardized protocol for proper disposal 
of pharmaceuticals in hospice care.  The updated protocol was used to develop a leading edge 
document of best management practices and an education program for GHPCO and GAWP.  The 
motivation for this project was to develop best management practices so that hospice may use 
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Methodology   
Several research methods were utilized in this investigation of pharmaceutical disposal 
practices of hospice nurses in a residential setting.  As an explanatory case study focusing on the 
actions and attitudes of hospice nurses, we employed personal interviews, a survey, a focus 
group, implemented a pilot study, and conducted secondary research reviews.  These methods 
served to verify current disposal practices, gain feedback on alternative methods, and provide an 
understanding of the logistics that needed to be considered to sucessfully develop alternative 
management practices to reduce water pollution.  Specifically, our study addresses the following 
questions: 
 Question 1:  Do hospice providers know that flushing has a negative impact on     
    water quality? 
 Question 2:  Can the authors develop an alternative flushing method that will not: 
a) Increase operational costs? 
b) Increase the providers’ workload? 
c) Disrupt the treatment process for the patient or grieving process for the 
family? 
d) Interfere with legal or regulatory restrictions? 
e) Compromise established safety protocols? 
 Question 3:  Will hospice nurses change their pharmaceutical disposal practice? 
We expected to gain a thorough understanding of the issues involved in pharmaceutical disposal 
by hospice providers in a residential setting, the pros and cons of various alternative disposal 
practices, and identify an improved alternative to flushing that will not impact cost, add burden, 
or reduce safety while eliminating this water pollutant source.  We suspected many hospice 
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providers were flushing pharmaceuticals.  It is easy and has been recommended by several 
government agencies including the U.S. Food and Drug Administration (2010) (see Appendix 
A).  We were curious to learn if hospice providers were aware of PPCP contamination concerns, 
have received any training in disposal practices, and if there is a policy in their organization 
regarding what to do with left over pharmaceuticals.   
To ensure active participation within the hospice community and the water industry, we 
established partnerships with the leadership of two key nonprofit organizations: The Georgia 
Hospice and Palliative Care Organization (GHPCO) and the Georgia Association of Water 
Professionals (GAWP).  The GHPCO is a group of 102 member organizations that provides 
information, education, and advocacy to hospice and palliative care providers operating state-
wide in Georgia.  The GAWP is a member organization of water utilites, engineering and 
environmental consultants, and licensed professionals that serves to educate and assist with water 
resource protection and management.   
 
Georgia Hospice and Palliative Care Organization  
After contacting and meeting with GHPCO’s Executive Director, Jennifer Hale, to learn 
more about hospice care, we explained our intention to investigate pharmaceutical disposal 
practices and asked if GHPCO would be interested in helping to facilitate this project.  We 
brainstormed with her on how to implement the research and decided on forming a focus group 
and creating a survey instrument.   
Georgia Association of Water Professionals 
To recruit support for this project, we met with GAWP’s Communications Director, 
Bryan Wagoner, and asked for GAWP’s sponsorship in the form of meeting space and 
participant incentives.  We also asked for feedback on documents and endorsement of any 
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project deliverables to ensure that member utilities would utilize the materials.   It should be 
noted that both researchers are members of and active volunteers for GAWP.  Participant 
incentives sponsored by GAWP included gift certificates for one dozen donuts to organizations 
with staff that submit completed surveys.  The value of the certificate was approximately $7.00.  
GAWP also provided lunch at the four focus group meetings.  Lunch was valued at 
approximately $8.00 per person.   
 Using individual nurses as our unit of analysis, respondents were selected through 
purposive sampling from their respective organizations.  The focus group and survey subjects 
were provided with project background information and contact information to ensure informed 
consent was established as a condition for participation in this study (see Appendix B).  With 
endorsement from GHPCO, Marietta-area member organizations were invited to participate in 
the focus group.  All 102 GHPCO member organizations were e-mailed to solicit voluntary 
participation from their nursing staff in the survey (see Appendix C).  Only survey responses 
from nurses who reported being responsible for medication disposal were included in the data 
analysis.  To our knowledge there were no risks involved for study participants.  We believe that 
the participants gained a better understanding of the environmental health problems associated 
with flushing pharmaceuticals.           
 
Data Collection Procedures 
 By using several sources of evidence, we hope to ensure validity and produce reliable 
education products that will serve to effectively address residential disposal methods used by 
hospice providers.  To further ensure our recommendations are practical as well as beneficial to 
the environment, we asked the focus group members to implement a pilot study using the 
proposed Best Management Practice (BMP) and provide critical feedback regarding their 
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experiences using the new protocol.  Based on these recommendations, we developed a final 
BMP and education plan to be published by the GAWP for member utilities across the state, to 
reach local hospice providers in their area and address the impact of flushing pharmaceuticals.   
     
Focus Group Formation 
To bring together a group of hospice workers willing to openly talk about the realities, 
problems, and concerns associated with medication disposal, we needed to find people who 
would be willing to answer our questions frankly, provide critical feedback, and offer practical 
advice throughout the research process.  Jennifer Hale agreed to introduce us to GHPCO 
members by contacting hospice organizations operating in the Marietta, Georgia area with our 
invitation and request for their assistance with the project.  We successfully recruited participants 
from three local agencies who agreed to meet with us to learn more about the project.  During 
our initial meeting, we introduced the project, asked for feedback on how best to develop a 
successful education campaign to reach hospice nurses with our pollution prevention message, 
shared our initial draft of the survey for feedback, and scheduled three future meeting dates. 
 
Survey Development 
In preparation for our Institutional Review Board approval request, we created several 
survey questions.  Our initial plan was to utilize an online survey site to collect data.  We 
intended to draft an e-mail, with the survey link embedded in the message, inviting hospice 
nurses to participate.  Jennifer Hale committed to forwarding the message to member 
organizations, encouraging participation.  Our focus group formation meeting provided us with 
an opportunity to get expert feedback in refining the survey questions and resolving 
implementation logistics.  Several questions were revised and the question order restructured 
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based on their suggestions.  We also learned from the focus group that most hospice nurses do 
not have access to an office computer but they do meet routinely, twice monthly in most cases, 
as a group and it was during these meetings that the nurses would most likely be approached to 
complete the survey. Based on their recommendation, we switched to a paper survey.  The 
invitation was e-mailed with our message as planned but the survey was attached as a PDF with 
instructions to either fax or mail responses.  In addition, the focus group recommended providing 
a small incentive to nurses that participate.  In response, GAWP agreed to provide gift 
certificates for a dozen donuts to each organization with staff that participated.  Once collected, 
the responses were coded and entered into an Excel spreadsheet and Number Crunching 
Statistical System (NCSS).  Frequency tables and cross tabulation reports were run in the NCSS 
database.  The results were graphed and shared with the focus group.   
 
Focus Group Meeting One 
After sharing the frequency tables of the survey results with the group and reviewing the 
findings, we discussed the merits of the disposal methods reported by the survey respondents.  
The focus group quickly came to consensus on the protocol it preferred to promote as a BMP.  
All three focus group organizations agreed to pilot this new method for one month.  To support 
the pilot project, we created a written protocol, a disposal method feedback form, and a fact sheet 
explaining water quality concerns as related to the flushing of pharmaceuticals.  We also 
discussed what should be developed for the education campaign including creating a how-to 
video that demonstrates the BMP, a presentation for utilities to use in reaching out to hospice 
providers, and educational articles for GHCPO’s and GAWP’s newsletters.  In addition, we 
asked the focus group participants to share their organization’s written disposal policies to 
supplement our secondary research.      
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Focus Group Meeting Two 
After reviewing the cross tabulation reports of the survey results and the findings, we 
shared the draft materials and solicited feedback to finalize the documents (protocol, feedback 
form, fact sheet) for printing.  GHPCO and GAWP both approved the final draft for publication 
and distribution.  We also shared the draft video script and obtained the endorsement of the 
concept and scheduled the filming as one of the activities to be completed during the third 
meeting.  For the pilot study, the focus group asked us to provide a disposal kit for each nurse in 
case the patient’s household did not have the required supplies on-hand.  We created and 
delivered 30 disposal kits, 10 kits were provided per organization.   
 
Focus Group Meeting Three 
After receiving nurse feedback from the pilot study and reviewing disposal protocol, we 
discussed how to move forward with changing disposal practices.  We filmed the educational 
and how-to video and discussed the logistics of establishing partnerships between water utilities 
and hospice providers.  We decided two presentations needed to be developed to assist water 
utilities in reaching out to local hospice organizations.  One would be an internal document that 
explains the relationship and logistics to be considered in establishing a partnership.  The second 
is an educational presentation that utilities can share with hospice staff regarding the pollution 
concerns associated with flushing pharmaceuticals.  It is pertinent to note here that two of the 
three hospice organizations participating in the pilot were not able to attend this meeting.  We 
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Variables and Definitions 
 Through the survey, we examined several aspects of nurses’ attitudes regarding concern 
for the environment including perceived patient concerns and reported participant concern over 
proper disposal, harm by hospice, and impact to drinking water quality, aquatic wildlife, and 
source water.  We should note here that study participants were self selected and we 
acknowledge this potential bias inherent in our process.  In addition, convenience sampling was 
used to select the focus group participants.   
  The survey responses were compared to several dependent variables including gender, 
age, medical experience, and hospice experience.  The survey also provided descriptions of both 
the methods of pharmaceutical disposal training being given to nurses and the type of disposal 
procedures being conducted by hospice providers.  This information provided the basis for focus 
group discussion on the development of an alternate BMP and education plan.  
 To facilitate clarity and understanding, the following industry-specific terms are defined, 
providing descriptions in greater detail of terms we use in this paper:   
 
Hospice Care:  “Care designed to give supportive care to people in the final phase of a terminal 
illness and focus on comfort and quality of life, rather than cure. The goal is to enable patients to 
be comfortable and free of pain, so that they live each day as fully as possible. Aggressive 
methods of pain control may be used. Hospice programs generally are home-based…The 
philosophy of hospice is to provide support for the patient's emotional, social, and spiritual needs 
as well as medical symptoms as part of treating the whole person”  (Medicinenet 2003).  
Palliative Care:  “Palliative care (pronounced pal-lee-uh-tiv) is the medical specialty focused on 
improving the quality of life of people facing serious illness. Emphasis is placed on pain and 
symptom management, communication and coordinated care. Palliative care relieves symptoms 
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such as pain, shortness of breath, fatigue, constipation, nausea, loss of appetite and difficulty 
sleeping. It helps you gain the strength to carry on with daily life. It improves your ability to 
tolerate medical treatments. And it helps you to better understand your choices for care.  
Palliative care is not end-of-life care and is not the same as hospice. Hospice is focused on 
providing quality care to people in the last months of life who have decided to stop treatments 
meant to cure them.  Palliative care on the other hand can be provided from the time of 
diagnosis. You can have palliative care at the same time as curative treatment” (Get Palliative 
Care 2011).      
Diversion:  The DEA defines the diversion of medications as “the redirection of narcotic drugs 
and psychotropic substances from the legitimate distribution chain of medical and scientific use 
into illicit channels” (Herring et al 2008, 338; Spartz and Shaw 2009). 
Best Management Practice (BMP):  This term is used in the U.S. Clean Water Act to describe a 
type of water pollution control including procedures for controlling toxic pollutants associated 
with industrial discharges and nonpoint source pollutant management (U.S. Environmental 
Protection Agency 2007).  
Nonpoint Source Pollution (NPSP):  As defined by EPA, “nonpoint source pollution generally 
results from land runoff, precipitation, atmospheric deposition, drainage, seepage or hydrologic 
modification. The term ‘nonpoint source’ is defined to mean any source of water pollution that 
does not meet the legal definition of ‘point source’ in section 502(14) of the Clean Water Act. 
That definition states:           
 The term ‘point source’ means any discernible, confined and discrete conveyance, 
 including but not limited to any pipe, ditch, channel, tunnel, conduit, well, discrete 
 fissure, container, rolling stock, concentrated animal feeding operation, or vessel or other 
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 floating craft, from which pollutants are or may be discharged. This term does not include 
 agricultural storm water discharges and return flows from irrigated agriculture. 
Unlike pollution from industrial and sewage treatment plants, NPSP comes from many diffuse 
sources.  NPSP pollution is caused by rainfall or snowmelt moving over and through the ground. 
As the runoff moves, it picks up and carries away natural and human-made pollutants, finally 
depositing them into lakes, rivers, wetlands, coastal waters, and even our underground sources of 
drinking water” (U.S. Environmental Protection Agency 2010e). 
Pharmaceuticals:  Also referred to as drugs, medicine, and medication.  The authors use these 
terms unchangeably.   
Pharmaceuticals and Personal Care Products (PPCP):  According to EPA, pharmaceuticals and 
personal care products (PPCPs) are being discovered in our nation's waters at very low 
concentrations. Pharmaceuticals refer to prescription and over-the-counter therapeutic drugs and 
veterinary drugs. Personal care products refer to products used for personal and cosmetic reasons 
such as soaps, fragrances, and cosmetics (U.S. Environmental Protection Agency 2010a). 
Microconstituent:  Naturally occurring or man-made compounds detected in the environment 
which may impact the health and development of living organisms (Virginia Department of 
Environmental Quality 2011; Hunter et al 2008).   
Source Water:  Referring to where drinking water supplies are pulled from prior to treatment, 
source water can be ground water (aquifers) or surface water (rivers, lakes, streams, wetlands).    
Drinking Water:  Also known as potable water, drinking water refers to water that has been 
treated to ensure it is safe for consumption.        
Disinfection:  “Water disinfection means the removal, deactivation or killing of pathogenic 
microorganisms...The process of inactivating harmful and objectionable bacteria, cysts and other 
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microorganisms by various agents such as chemicals, heat, ultraviolet light, ultrasonic waves, or 
radiation…When microorganisms are not removed...water usage will cause people to fall ill” 
(Lenntech 2011). 
Wastewater:  Also known as sewage, wastewater refers to water that has been contaminated by 
human waste or commercial and/or industrial processes.  
  
 Using the research collected during this study, we have developed a comprehensive 
education program.  Deliverables include a piloted alternate disposal BMP (see Appendix D), an 
educational fact sheet (see Appendix E), newsletter articles targeting education at both hospice 
and water professionals, PowerPoint presentations targeting both hospice and water professional, 
an educational how-to video demonstrating the BMP, and an online presentation of our survey 
results.  Our research is also scheduled to be shared at GAWP’s annual conference in July of 
2011.  In addition, we discussed solicitation for product donations to supply free coupons for 
disposal supplies (liquid dish soap and zip-locking bags) to hospice providers for the supplies 
needed to perform the BMP.  Any donations received would be provided to GHPCO for 
distribution to member organizations.  With these resources in place, we have provided water 
professionals with the tools needed to help Georgia’s hospice providers to standardize their 
medication disposal methods and reduce water pollution. 
 
Findings 
 Three data sets were generated during this study.  Initial data collection was focused on 
demographic information of hospice nurses and their industry attitude regarding pharmaceutical 
disposal practices.  The collection instrument was in the format of a survey.  This information 
was used in conjunction with direct feedback from hospice practitioners who agreed to serve as 
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advisors in a focus group.  The focus group members helped develop strategies to reach out to 
their colleagues and advise on the content of education materials.  The third data set consisted of 
a pilot project that tested an alternate pharmaceutical disposal method recommended by the focus 




 The survey invitation was e-mailed in early December 2010 to 102 GHPCO member 
organizations with the incentive of a gift certificate for dozen donuts to each organization with 
nurses that participate in the study.  We allowed three weeks for surveys to be returned by either 
mail or fax.  In total, we received 137 completed surveys from 33 organizations.  Of these, 15 
surveys were eliminated from the study as the respondents indicated they were not responsible 
for pharmaceutical handling and/or disposal in their job duties.  The research analysis was 
performed on the 122 remaining surveys.   
 The initial analysis was compiled using the frequency of responses from each question.  
In terms of demographics, the survey participants were mostly female, with more than 10 years 
of medical experience, and less than 5 years of hospice experience.  Most were familiar with 
their organization’s pharmaceutical disposal policy, had received some training in this area, and 
felt their organization was very concerned about pharmaceutical disposal methods.  Most were 
also personally concerned about pharmaceutical disposal methods and indicated receptiveness to 
procedural changes.   
 Several questions about pharmaceutical disposal practices were focused on the 
respondents’ level of concern over harm by hospice, impact on drinking water quality, impact on 
aquatic wildlife, and impact on water sources.  We were interested in knowing if any 
demographic variables contributed to the participants’ responses.  We created cross tabulation 
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reports looking at these responses in relation to age, gender, medical experience, and hospice 
experience.  No statistically significant differences were found when looking at participants’ 
responses and age or hospice experience.  There were some differences observed when looking 
at gender and medical experience.     
As our survey utilizes feedback from all hospice nurses that self-selected to participate, 
the representativeness of our findings cannot be assured and we have to acknowledge the 
resulting concern over external validity inherent in the research design.  Nurses from 33 of 102 
possible organizations participated in this study.  Due to time constraints, it was not possible to 
utilize random selection of subjects or to replicate our data collection.  This is a limitation of our 
study that we openly recognize and hope to resolve in future projects.  However, our subject 
demographics do mirror studies conducted by other researchers and we are optimistic that this 
threat to our external validity is minimal.  We also utilized multiple sources of evidence, clearly 
defined our unit of analysis in this study, and adopted a holistic approach to our investigation in 
an attempt to ensure any threats to operational validity, internal validity, or reliability are 
adequately addressed.           
 
Gender Differences 
 Probability levels indicate a significant difference in response for gender when answering 
three questions.  However, of the 122 respondents only 9 (7 percent) were male.  This disparity is 
typical of the field.  “Approximately 5.4% of the 2.1 million R.N.s employed in nursing in the 
United States are men, according to the National Sample Survey of Registered Nurses conducted 
in March 1996 by the Health Resources and Services Administration” (Chung 2011).  In 
addition, of the 9 males that participated, one failed to respond on two of the three questions 
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where statistical differences were noted.  Despite the small sample size and problem of external 
validity, we note the responses to the three questions below as potential gender disparity. 
1. How concerned are your patients and/or their families regarding the drug disposal 
methods of their unused medications? (see Figure 1).   
2. Indicate your level of concern for impact of pharmaceuticals on water sources such as 
lakes and rivers (see Figure 2).  
3. Would you be receptive to procedural changes regarding disposal of patients’ unused 
drugs? (see Figure 3).  
  31 
 
            
 
Figure 1. 
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 The receptiveness to procedural change answers included several qualifying elaborations 
submitted by those that responded with maybe.  Responses included dependence on reviewing 
the new procedure, who and what would be effected by the change, costs, regulatory/legal 
compliance, and eco-friendliness.  Our results indicate that hospice nurses are quite conscience 





 Probability levels indicate a significant difference in responses when looking at years of 
experience in the medical field and two areas: 
     1.  Concern over the potential harm from drug disposal methods by hospice (see Figure 4). 
 
     2.  Concern over the impact of pharmaceuticals to aquatic life (see Figure 5). 
 
As you would expect, those with the most nursing experience are older.  However, we learned 
from our focus group that hospice has a high turnover rate.  Figure 6 shows that medical 
experience and hospice experience can differ greatly.   One might expect there to be a higher rate 
of employee retention in this field.  However, as indicated in Table 1, we found that 86 percent 
of our participants had less than 10 years of experience working in hospice.  This is pertinent 
when considering education efforts targeted at hospice providers.  High turnover rates indicate 
that water utilities should establish ongoing education partnerships to ensure that our pollution 
prevention message reaches incoming staff.    
Table 1. 
Breakdown of Hospice Experience Reported 
by Nurses Providing Care in Georgia 
 Count Percentage 
Less Than 5 years with Hospice 66 54 
6-10 years with Hospice 39 32 
11-20 years with Hospice 16 12 
20+ years with Hospice 1 1 
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Disposal Methods  
 
 Our survey shows that 28 percent of the respondents report flushing patient’s unused 
pharmaceuticals.  This is consistent with published data on hospice practices (Spartz and Shaw 
2009).  Having established the flushing method is being used in Georgia by hospice providers, 
we can conclude that a pollution problem needs to be addressed in Georgia.  Table 2 is a 
breakdown on reported disposal methods.   
Table 2.  
Reported Pharmaceutical Disposal Methods 
Being Used by Hospice Nurses in Georgia 
Mix with undesirable then garbage 68% 
Flush 28% 
Garbage 3% 
Take Back Program 1% 
 
Many variations of undesirable substances were reportedly being mixed with medications to 
render them unusable.  Products including sand, cat litter, detergent, coffee grounds were 
specifically noted.  Eighteen percent of our respondents reported flushing as their only disposal 
method.  This is likely in response to the FDA’s list of medicines recommended for disposal by 
flushing.  This is a recommendation, not a regulation.  However, as some providers are likely to 
follow this procedure, they are probably flushing everything to ensure compliance with this 
recommendation.  There is an added burden if a second disposal method is utilized.  These 
barriers, of compliance and added workload, may discourage nurses from adopting a new 
disposal method.   
 
The Focus Group 
 
 The survey data served as a starting point for exploring how to effectively reach out to 
hospice providers, what needs to be said, and what tools are required to convey the message 
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effectively.  The focus group meetings provided an opportunity to talk directly with hospice 
nurses about our survey findings and obtain their expert guidance in developing an education 
plan to address our concerns and change pharmaceutical disposal practices. 
  Prior to launching the survey, we met with GHPCO and three local hospice 
organizations to introduce the project and establish the ground rules for our working group.  
Participants shared feedback on the draft survey, helping us validate the questions, and discussed 
the disposal methods used by their organizations.  We asked each organization to share their 
disposal policies and received several for review.  Additionally, we later learned that hospice 
providers are required to review these policies with patients and their families.  This mandate 
ensures the method is explained routinely.  Pharmaceutical disposal methods are also reviewed 
by state surveyors during recertification for each organization’s license renewal.  Therefore, 
discussion regarding our proposed change should not be difficult to initiate.       
 After closing the survey, we facilitated three focus sessions.  Initial discussions focused 
on reviewing the survey findings.  Of the respondents, 93 percent reported receiving some 
training on disposal of pharmaceuticals.  We looked closely at the type of pharmaceutical 
training participants reported receiving.  Over 30 training combinations were noted.  Once 
organized, we compiled frequency responses for ten methods as illustrated in Figure 7. 
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Based on the data, there is room for innovation as well as opportunity to utilize traditional 
methods to reach nurses with our educational message.  We also noted that 93 percent of the 
respondents reported that they have never worked with their local water utility.  Clearly there is 
an opportunity to develop a partnership between the two industries. We asked the focus group to 
consider what a partnership between the two industries would look like and what materials 
would need to be developed to assist in building this relationship.   
 
The Education Plan     
 Both GAWP and GHPCO have several mechanisms in place to facilitate our outreach 
efforts.  Newsletters, websites, and conference presentations will be used to communicate our 
education message to members.  Beyond using these traditional methods, we tried to learn if 
there were other ways water utilities could reach out to hospice providers.     
 During the focus group meetings, we learned that hospice nurses were really only focused 
on the disposal of controlled substances.  Other medications, those not of concern for diversion 
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or accidental poisoning, are left with the family.  Considering this, we decided our BMP needed 
to reach beyond the hospice and water industry.  It should be a method the entire community 
could use for disposal of expired and unwanted medications.  The idea of creating a video was 
explored.  A video is appealing because it could be used to showcase the disposal protocol and 
explain the pollution concerns associated with pharmaceuticals in our waterways.  It could also 
be designed to speak to a broad audience.  The focus group decided the video should be part of 
the education plan and agreed on a humorous approach with several “we used to believe” 
scenarios discussed as a way to show how we have learned through history and have changed our 
beliefs and behaviors.  With this concept, we developed a script and filmed the video during the 
final focus group meeting.   
 Our education plan, initially designed for use by water utilities to facilitate 
communication with hospice organizations regarding water industry concerns over flushing as a 
pharmaceutical disposal practice, expanded to include outreach to the general public.  In addition 
to the video, we created an education fact sheet that provides background and context to the 
pharmaceutical disposal issue and recommends an alternative practice to flushing.  These 
education materials are appropriate for a community audience and can be used for public 
education programs.   
 The final component of the education plan is the development of outreach tools for water 
utilities to use in reaching hospice organizations.  Based on focus group feedback, two 
presentations were needed.  One is an internal presentation with a water industry perspective, 
designed to provide GAWP member organizations with what they need to consider before 
contacting a potential hospice partner.  Components include how to find local hospice providers, 
who to contact within the organization, and what service to offer the organization once you make 
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contact.  The second is a pharmaceutical disposal how-to presentation using a hospice 
perspective.  We learned that hospice providers are required to offer education to staff on proper 
drug disposal.  Water utilities will have the ability to provide the service of pharmaceutical 
disposal training sessions to hospice organizations using the materials developed during this 
project.   
 Beyond offering hospice providers free mandated staff training, hospice also has an 
ongoing need for volunteers that water utilities can help promote to employees and customers.  
Through our focus group we learned that hospice providers are mandated by law to have a 
minimum of 5 percent of patient care hours provided by volunteers.  Volunteer care includes 
visiting or providing a service such as walking dogs, yard work, reading, or crafting for patients.  
Providers are specifically looking for veterans to visit with veterans receiving hospice care.  
They also need administrative help at hospice offices.  With this ongoing need for volunteers, 
water utilities have an opportunity to partner with hospice organizations to encourage water 
protection practices and provide support for the needs of the community. 
 
Formal Endorsement of the BMP 
 To become incorporated into the formal messaging of the organization, we needed to 
understand how a new disposal method could be adopted as official policy.  Our focus group 
advised that for large organization, corporate endorsement is needed for a policy to be 
implemented.  It is apparently not a difficult procedure but it does take time.  The first step is to 
get local support, then regional leadership reviews the policy, and finally national management 
would need to approve the change.  New policy must demonstrate potential outcomes and 
explain why the company should make the change.  The focus group noted that cost is always an 
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important consideration.  They also recommended submitting our policy and education materials 
to the Georgia Board of Pharmacy (GBP) for their official endorsement.  Upon completion of 
this project, all materials will be submitted to GBP for feedback and approval     
 In discussing the logistics of obtaining endorsement, we asked what was needed to gain 
GHPCO’s official recommendation and encourage member organizations to adopt our BMP.  
We learned that the project would need to be presented to the GHPCO Board of Directors for 
support.  With the Board’s agreement, the BMP could be published on GHPCO’s website as a 
Georgia-specific practice endorsed by GAWP (and hopefully by GBP).  GAWP approved the 
education materials and proposed BMP prior to the implementation of the pilot study. 
 Although we will not be able to obtain a measurement of project impact through this 
study, we do have an opportunity to establish a benchmark on how many organizations use 
flushing as a pharmaceutical disposal practice.  GHPCO is willing to put a question in their 
annual membership survey, conducted every September, about the type of disposal method used 
by the organization.  We plan to work with GHPCO on the exact working of this question so we 
can obtain an accurate picture of pharmaceutical disposal practices in order to target further 
education efforts as needed.   
 
The Pilot Project 
 During the initial meeting of the focus group, we discussed conducting a pilot study using 
a method developed by the focus group.  One of the nurses recommended using liquid 
dishwashing soap as an undesirable substance that could be mixed with the medication to render 
them un-consumable.  We examined several options and discussed the alternative options with 
the members of the focus group prior to making a final decision.  The focus group decided to test 
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the initial recommendation, using liquid dishwashing soap as the undesirable substance, with 
everything sealed in a plastic bag.  These materials are inexpensive items that can be found in 
most homes.  The nurses agreed to try out different soaps and various amounts of added water 
and share their recommendations via e-mail to finalize the proposed method for our pilot study.  
Each organization agreed to pilot the proposed method for one month and report back their 
findings.  To support the pilot, we created a fact sheet, a written disposal procedure, and a 
comment card for protocol feedback (see Appendix D and E).  Attention was given to ensure that 
the wording did not conflict with the federal guidelines published by the Office of National Drug 
Control Policy (2009).     
 In discussing the implementation of pilot project, the focus group asked for disposal kits 
to ensure the nurses had the necessary supplies on hand.  We discussed what was needed in each 
kit and decided to include: 
• 5 sandwich sized zip-sealing bags, 
• 5 gallon sized zip-sealing bags, 
• 1 small bottle of liquid dishwashing soap, 
• 1 Pharmaceutical Disposal Factsheet, and 
• 1 Pharmaceutical Disposal Method Sheet. 
Each hospice provider had 10 nurses on staff so 30 kits were assembled.  Each provider was also 
given 15 feedback forms.  One member from each organization agreed to be the study 
representative who would ensure that the pilot materials were distributed and feedback forms 
were collected.  The kits were delivered to each organization shortly after the second meeting to 
ensure that the pilot study was given a full month for implementation.   
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 The proposed disposal method was implemented with ten hospice patients during the 
pilot study.  Only one participant reported that the proposed method was more expensive than the 
method usually used.  This specific provider instructs nurses to mix medications with kitty litter 
or coffee grounds.  The focus group did not agree with the nurse.  The group felt that the 
operational costs would be the same or even slightly less.  The current method is to purchase a 
large bag of inexpensive cat litter.  Each nurse carries a large zip-sealing plastic bag of cat litter 
in case the home they are working in does not have coffee grounds or cat litter to mix with the 
medication.  The focus group felt that since the hospice provider is already purchasing zip-
sealing plastic bags and the expense of liquid dishwashing soap is minimal, then operational 
costs would not increase using the proposed method.   
 We had previously considered soliciting donations for free product coupons for supplies 
to offset the cost of switching pharmaceutical disposal methods.  We asked the group if utilities 
could help by providing supplies or whether we should pursue requesting coupon donations for 
materials.  Since there is little to no cost associated with this protocol, they did not think it was 
necessary to request for assistance. 
 Hospice nurses participating in the pilot study were the initial audience receiving our 
message.  We wanted to make certain that the reader understands the issue and is empowered to 
act responsibly.  With pilot study participants’ feedback, we will be refining the education 
materials for submission and official endorsement.   
 Regarding the logistics of the pilot study, we found it difficult to obtain feedback from 
the hospice providers who assisted with data collection.  Due to the lack of predictability 
regarding when medication disposal practices were implemented in the field there was limited 
opportunity for data collection during the initial study period.  We extended the pilot three more 
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weeks in an attempt to collect additional feedback and did obtain four more responses.  
However, we had hoped to achieve more diversity in the responses including aspects such as the 
number of nurses using the proposed method, the number of occurrences where the proposed 
methods was used in the home, and more extensive detail in terms of critical feedback from 
those who participated.   
                
Discussion 
The Overarching Issue 
Although seemingly an emerging issue, traces of pharmaceuticals and Personal Care 
Products (PPCPs) have been present in drinking water since they were first used by the consumer 
(Snyder et al 2008, 67).  The largest pathway of pharmaceuticals in water sources originate from 
wastewater effluents.  Pharmaceutical compounds in water are categorized as “non-point source 
pollution” because they do not originate from one discernable source, but from a multitude of  
homes and businesses (U.S. Environmental Protection Agency 2010e).  Chemical compounds 
from pharmaceuticals, referred to as microconstituents, are contributed to wastewater streams 
largely through excretion of the consumer (Rodriguez-Mozaz and Weinberg 2010), by disposal 
of medication (Daughton 2007), and sometimes industrial discharges or runoff (Snyder et al 
2008).  Some may perceive microconstituents in water sources as a new occurrence; however the 
detection of these compounds is the result of tremendous strides in analytical technology (Snyder 
et al 2008).  Decades ago, monitoring instrumentation measured concentrations of parts-per-
million but today it is possible to measure microconstituents to the level of parts-per-trillion 
(Snyder et al 2008, 67).  While it is difficult to conceptualize the difference between these 
analytical levels, they represent incredible technological advances in water monitoring.  
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Societal Behavior 
Finding effective solutions to the complex issue of pharmaceutical compounds in water 
sources will require a broad focus (Daughton 2010).  Pharmaceutical disposal methods are only a 
small part of the larger issue of the increasing dispersion and utilization of pharmaceuticals.  The 
rapid increase in consumption of pharmaceuticals results in higher concentrations of 
microconstituents in water, whether attributed through disposal methods or as a by-product of 
excretion.  Trends in societal behaviors have led to the prolific distribution of medications by 
pharmaceutical manufacturers, pharmaceutical sales representatives, physicians, pharmacists as 
well as the consumption of the medications by the consumer (Daughton 2010).  Dr. Christian 
Daughton, an expert in PPCPs for the USEPA, reminds us that “the focus of efforts addressing 
the issue of drug waste needs to be on solutions for minimizing the generation of waste at the 
outset rather than on how to handle it once generated”   (Daughton 2010, 29).  In other words, 
reducing demand will reduce supply and subsequently the inventory that will need to be 
discarded.  This is definitely true.  However, from the perspective of the water industry, there 
should be more concise and deliberate approach to determine the extent of the problem and what 
steps need to be taken to resolve it.  The water industry is responsible for the public health of its 
consumers and as a collective group should work to ensure the quality of the product we deliver. 
 
Advanced Treatment 
As previously outlined, both the wastewater and the water treatment process traditionally 
include a series of standardized stages.  Water and wastewater treatment has two vital steps, 
filtration and disinfection (Pontius 2008, 20).  The filtration and disinfection of water and 
wastewater dramatically changed the quality of life in the United States since it was first 
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implemented in the early 1900s (Pontius 2008).  Many other countries in the world continue to 
battle waterborne diseases like typhoid or cholera, diseases that have been eradicated in the 
United States through water and wastewater treatment processes.  Conventional treatment 
techniques have been extremely successful in protecting the public and environmental health 
over the last 100 years.  While conventional treatment methods remove microorganisms, these 
techniques are not as effective in the removal of microconstituents (Snyder 2008).  In order to 
effectively remove the majority of microconstituents from water, the utilization of advanced 
treatment methods will be necessary (Hunter et al 2008).   
 Advanced treatment supplements the conventional treatment processes by removing a 
broader spectrum of microconstituents.  Some of these advanced treatment processes include 
granular activated carbon (GAC), ozone disinfection, and reverse osmosis (RO).  The 
effectiveness of each type of advanced process is based on the type of process used, the specific 
microconstituent to be removed, and the type of water to be treated,  water or wastewater (Hunter 
et al 2008, 48).  For example, ozone disinfection is more effective at removing Ibuprofen from 
wastewater than the granular activated carbon process is at removing the same compound from 
drinking water (USEPA 2010c, A-12, A-22).  It is important to remember that a process that 
removes one microconstituent does not necessarily remove all of them (Snyder et al 2003).  
Therefore, to remove a complex assortment of microconstituents may require multiple advanced 
treatment processes (Snyder et al 2008).  Furthermore, the implementation of advanced processes 
to a treatment facility is a large infrastructure upgrade.  This improvement will result in a 
significant financial investment by water utilities, inevitably trickling the expense down to  
customers.  Advanced treatment is effective at microconstituent removal, however, the feasibility 
of adding this type of infrastructure expansion is questionable when considering the lack of 
  45 
 
            
 
evidence linked to negative human health effects.  Further research on the effects of 
microconstituents will be crucial to determine the cost benefit of implementing any advanced 
treatment processes in public infrastructure. 
   
Legislation 
 Technological advances in detection methods have increased exponentially in recent 
decades, quickly outpacing advances in water treatment processes (Snyder et al 2008, 19).  
Modern detection methods provide sensitivity analysis of parts-per-billion and parts-per-trillion  
(Hoffbuhr 2009, 10).  This measures the concentration of a chemical by unit volume of water.  
To grasp the sensitvity of this type of detection, consider that one part-per-billion is the 
equivalent to “one-half an inch in the distance between the earth and the moon” (Snyder 2008, 
1).  These concentration limits are so tiny that they are difficult to comprehend.  It is also 
important to remember that just because a compound can be detected does not necessarily mean 
it is harmful (Pontius 2008).  Although some may call for regulatory action to set limits on 
microconstituents, in water sources, this may not be the most suitable resolution.  It would better 
serve the public to have more clarity on the effects of exposure levels before implementing 
regulatory limits.   
However, legislation is a powerful measure that can be used in the reduction of 
pharmaceuticals in water sources.  There are currently no federal regulations regarding the 
concentrations of pharmaceuticals in water (Rodriguez-Mozaz and Weinberg 2010).  Would it be 
prudent to enact legislation on drinking water standards since the effects of microconstitutents 
are still unclear?  Regulation of microconstituents concentration limits would result in dramatic 
increases for the cost of the water that is used in every component of life.  Because water is used 
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in the manufacturing and use of every conceivable product from food processing to car 
production, increases in water cost would impact the overall economy much like that of the cost 
of oil. Therefore, new regulation should be carefully considered because additional mandates on 
water treatment will have broad implications on the economy at large.  The response of federal 
agencies and local utilities will be distilled down to public values.  Do people want to pay more 
for their water in order to remove microconstituents or will the public prefer to have more 
substantial findings from research before further legislation is enacted?     
The Drug Disposal Act of 2010 is a judicious step on the part of the federal government 
to determine the environmental impact of pharmaceuticals in water sources (Water Environment 
Federation 2010). The Drug Disposal Act may provide clarity for federal agencies to synchronize 
their directives regarding pharmaceutical disposal.  This legislation prompts federal agencies to 
investigate the health effects of microconstituents, develop an education plan, and provide more 
flexibility for local take-back programs.  This act will also provide funding for research and 
educational outreach programs.  As a result, the findings from the USEPA’s research may 
determine the steps, if any, that utilities should take to treat microconstituents in water sources. 
 
Public Administration Principles 
This project is a sound demonstration of public administration principles at work.  With 
the on-going concern about the preservation of our water resources here in Georgia, it is more 
important than ever to protect the quality of accessible water sources.  A public administrator 
working in the water industry has the task of managing water resources shared by the 
community.  Therefore, one must take a holistic approach to confront challenges so that adequate 
quantity and quality of our water supplies may be ensured for the future.  Although often taken 
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for granted, clean water is the engine for our economy.  Every industry imaginable relies on 
water to function, from manufacturing airplanes to poultry farming and recreational parks to 
restaurants.  There is a significant relationship between the health of our economy and the health 
of our water resources. 
Much like oil, the price of water will have a great impact on the price of goods and 
services and consequently the overall economy.  When contemplating pharmaceuticals in our 
water resources, some may feel that legislation and/or advanced treatment processes will be a 
simple solution to this problem.  However, the enactment of legislation and/or the 
implementation of advanced treatment processes will inevitably result in higher water rates.  The 
public administrator must evaluate the need to respond to this issue. Since the effects of 
pharmaceuticals in water are not yet known, it may not be prudent to pursue a reduction in their 
concentrations.  Further research is needed to clarify negative health effects on humans, if they 
do indeed exist.    Perhaps enacting legislation and advanced water treatment may be effective in 
removing microconstutients but these actions may be an exaggerated response to the problem.  
An overreaction will reduce the efficiency in the current treatment process. 
Finally, the public administrator must consider equity when determining an appropriate 
response to the challenge of emerging contaminants.  Actions that will increase water rates will 
impact social equity.  Rate increases may be more obtrusive on low-income families, placing a 
disproportionate burden on this segment of the population.  The public administrator should 
determine the public value placed on removing microconstitutents from water.  Will people be 
willing to pay more for water when long term effects of microconstituents on human health are 
unclear?  Are the negative effects on aquatic life motivation enough for the public to support 
large scale changes to the water system infrastructure?  Currently, these questions cannot be 
  48 
 
            
 
answered but future research regarding the public’s value of water will direct the approach of 
public administration practitioners.  Public support will help public administrators to manage the 
quality and cost-effectiveness of our most valuable natural resource. 
 
Conclusions 
Education and Outreach 
For decades, we have been taught that flushing was the most suitable form of 
pharmaceutical disposal.  However, with the impacts of this practice coming to light, experts 
have determined that this practice is no longer appropriate. It will be necessary to re-educate the 
general public so that their medication disposal practice transitions from the flushing to a method 
such as the one suggested in this study.  It will take a concerted effort by federal, state, and local 
agencies to thoroughly promote a revised message for disposal practices.  A large scale 
promotion of this kind will require a significant investment of time and money.   
Additionally, the absence of a standardized disposal infrastructure prohibits proper 
pharmaceutical disposal.  Some local utilities, law enforcement agencies, and pharmacies have 
established take-back programs but the cost and legal requirements are considerable.  In order to 
facilitate a disposal infrastructure, it is important that local agencies have the flexibility and 
resources necessary to make cost-effective collection stations. There is hope that the new Drug 
Disposal Act of 2010 may provide leeway for local agencies to put such a system in place. 
 
Project Partnership 
This research has provided the opportunity to partner with hospice professionals through 
the Georgia Hospice and Palliative Care Organization (GHPCO) to form a focus group and get 
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their candid perspective about disposal practices.  The GHPCO membership participated in our 
state-wide survey which concentrated on disposal practices and pollution impact perception by 
hospice professionals.  The findings of our survey illustrate that hospice nurses are concerned 
about potential harm from pharmaceutical disposal by their industry.  This answers the first 
question posed in our research, do hospice providers know that flushing has a negative impact on 
water quality?  Hospice providers are aware that flushing has a negative impact on water quality.  
In the second question, we considered whether an alternative to the flushing method could be 
established that would not increase operational costs, workload, disrupt the grieving process of 
the family, interfere with legal restrictions, or comprise safety protocols.  We were successful in 
the development of a disposal protocol that would fall within these parameters.  Finally, our 
research was designed to determine if hospice nurses would be willing to change their 
pharmaceutical disposal practices.  Over 90 percent responded that they would be receptive to 
possible change in their disposal method.  With the survey results, we were encouraged to find 
that 93 percent of respondents had received training from their company regarding disposal 
methods.  Additionally 68 percent were already using a similar protocol to the method we are 
proposing, which is to put all unused medications in a zip-sealing bag and mix with an 
undesirable substance such as liquid dishwashing soap.   
 
Being Part of the Solution 
The enormity of the issue of pharmaceuticals in water sources will require education and 
modification of many current social norms.  However, the “journey of a thousand miles begins 
with the first step.”  Therefore, this research has been framed around a manageable scope, with 
the collaboration of two statewide professional organizations, the Georgia Association of Water 
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Professionals (GAWP) and the Georgia Hospice and Palliative Care Organization (GHPCO).  In 
bringing these two associations together, we hope to establish a partnership between 
professionals in the water industry and those in the hospice sector to increase awareness of the 
contribution of “nonpoint source pollution” through flushing pharmaceuticals.  With the support 
of the GAWP and GHPCO, we have created education tools that will enable water utilities to 
reach out to their local hospice providers and establish a pharmaceutical disposal protocol. The 
survey, focus group, BMP protocol, video, fact sheet, articles, and presentations that were 
developed through this project can be used in outreach efforts for hospice professionals, water 
professionals, as well as the general public.  Of all the possible actions to achieve reduced 
microconstituents in water sources, education is the most essential.  We need to understand that 
our own actions, however large or small, have consequences for the world around us.  Ultimately 
it will take the support of everyone to protect and preserve our water resources for the next 
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MEDICINES RECOMMENDED FOR DISPOSAL BY FLUSHING 
This list from FDA tells you what expired, unwanted, or unused medicines you should flush down the 
sink or toilet to help prevent danger to people and pets in the home. Flushing these medicines will get rid 
of them right away and help keep your family and pets safe. 
FDA continually evaluates medicines for safety risks and will update the list as needed. 
Medicine Active Ingredient 
Actiq, oral transmucosal lozenge * Fentanyl Citrate 
Avinza, capsules (extended release) Morphine Sulfate
Daytrana, transdermal patch system Methylphenidate 
Demerol, tablets * Meperidine Hydrochloride 
Demerol, oral solution * Meperidine Hydrochloride 
Diastat/Diastat AcuDial, rectal gel Diazepam 
Dilaudid, tablets * Hydromorphone Hydrochloride 
Dilaudid, oral liquid * Hydromorphone Hydrochloride 
Dolophine Hydrochloride, tablets * Methadone Hydrochloride 
Duragesic, patch (extended release) * Fentanyl
Embeda, capsules (extended release) Morphine Sulfate; Naltrexone Hydrochloride 
Exalgo, tablets (extended release) Hydromorphone Hydrochloride 
Fentora, tablets (buccal) Fentanyl Citrate
Kadian, capsules (extended release) Morphine Sulfate
Methadone Hydrochloride, oral solution * Methadone Hydrochloride 
Methadose, tablets * Methadone Hydrochloride 
Morphine Sulfate, tablets (immediate release) * Morphine Sulfate
Morphine Sulfate, oral solution * Morphine Sulfate
MS Contin, tablets (extended release) * Morphine Sulfate
Onsolis, soluble film (buccal) Fentanyl Citrate
Opana, tablets (immediate release) Oxymorphone Hydrochloride 
Opana ER, tablets (extended release) Oxymorphone Hydrochloride 
Oramorph SR, tablets (sustained release) Morphine Sulfate
Oxycontin, tablets (extended release) * Oxycodone Hydrochloride 
Percocet, tablets * Acetaminophen; Oxycodone Hydrochloride
Percodan, tablets * Aspirin; Oxycodone Hydrochloride 
Xyrem, oral solution Sodium Oxybate
*These medicines have generic versions available or are only available in generic formulations.                     
List revised: March 2010 
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IRB Consent Documents 
 
December 1, 2010 
 
Kimberly P. Holland and Jennifer L. McCoy, 
Georgia Association of Water Professionals 
 
Re: Focus Group for Kennesaw State University, MPA Program, Public Service Practicum 
Changing Behavior: Can Water Professionals Transform Pharmaceutical Disposal 
Practices of Hospice Workers? 
 
To GHPCO Members: 
 
As part of our graduate work, we are conducting research that will provide public awareness of 
pharmaceuticals as a non-point source of water pollution and introduce reduction measures. We 
are conveying a focus group in January 2010 and are asking for your help in gathering data. We 
will hold a series of focus group meetings in Marietta to discuss secondary research findings, 
survey results, and brainstorm alternative practices and education strategies. We anticipate a 
maximum of 4 focus group meetings to be held January – March 2011. Each focus group 
meeting will last approximately 2 hours. Lunch will be provided by the Georgia Association of 
Water Professionals at each focus group meeting to thank participants for their assistance. 
 
Focus group participants should be at least 21 years old. Discussions during the meetings along 
with participants’ contact information and GHPCO member affiliations will be completely 
confidential. Results will be used to help develop an alternative pharmaceutical disposal protocol 
and education program. Our project results will be shared with participants at www.gawp.org. 
 
This study is being conducted under the supervision of our faculty advisor, Dr. Andrew Ewoh. 
Questions can be directed to Kim at 770-794-5227 or kholland@mariettaga.gov, Jennifer at   




Kimberly P. Holland    Jennifer L. McCoy 
Marietta Water    Cobb County Water System 
627 North Marietta Pkwy   662 South Cobb Drive 
Marietta, GA 30060    Marietta, GA 30060 
 
The purpose of this research has been explained and my participation is voluntary. I have the right to stop 
participation at any time without penalty. I understand that the research has no known risks, and I will not be 
identified. By completing this survey, I am agreeing to participate in this research project. 
 
THIS PAGE MAY BE REMOVED AND KEPT BY EACH PARTICIPANT 
 
Research at Kennesaw State University that involves human participants is carried out under the oversight of an 
Institutional Review Board. Questions or problems regarding these activities should be addressed to the Institutional 
Review Board, Kennesaw State University, 1000 Chastain Road, #0112, Kennesaw, GA 30144-5591, (678) 797-2268. 
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December 1, 2010 
 
Kimberly P. Holland and Jennifer L. McCoy, 
Georgia Association of Water Professionals 
 
Re: Survey for Kennesaw State University, MPA Program, Public Service Practicum 
Changing Behavior: Can Water Professionals Transform Pharmaceutical Disposal 
Practices of Hospice Workers? 
 
To GHPCO Members: 
 
As part of our graduate work, we are conducting research that will provide public awareness of 
pharmaceuticals as a non-point source of water pollution and introduce reduction measures. We 
have created a research design and are asking for your help in gathering data. The 16 question 
anonymous survey will take approximately 10 minutes to complete. Results will be used to help 
develop an alternative pharmaceutical disposal protocol and education program. Our project 
results will be shared with membership at www.gawp.org Again, your answers are completely 
anonymous. 
 
We are asking member organizations to have their nursing staff. Participants in the survey should 
be at least 21 years old. Organizations that submit completed surveys will receive a gift 
certificate from the Georgia Association for Water Professionals for a dozen donuts to thank you 
for your assistance. Please mail or fax the completed documents to Kim Holland at the Marietta 
Water address below or fax them to 770-794-5225. 
 
This study is being conducted under the supervision of our faculty advisor, Dr. Andrew Ewoh. 
Questions can be directed to Kim at 770-794-5227 or kholland@mariettaga.gov, Jennifer at    




Kimberly P. Holland   Jennifer L. McCoy 
Marietta Water  Cobb County Water System 
627 North Marietta Pkwy  662 South Cobb Drive 
Marietta, GA 30060   Marietta, GA 30060 
 
 
The purpose of this research has been explained and my participation is voluntary. I have the right to stop 
participation at any time without penalty. I understand that the research has no known risks, and I will not be 
identified. By completing this survey, I am agreeing to participate in this research project. 
 
THIS PAGE MAY BE REMOVED AND KEPT BY EACH PARTICIPANT 
 
Research at Kennesaw State University that involves human participants is carried out under the oversight of an 
Institutional Review Board. Questions or problems regarding these activities should be addressed to the Institutional 
Review Board, Kennesaw State University, 1000 Chastain Road, #0112, Kennesaw, GA 30144-5591, (678) 797-2268. 
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Survey of Pharmaceutical Disposal Practices of Hospice Workers 
 
1.  Gender: 
  Male 
  Female 
 
 
2.  Age: 
  18-29 
  30-39 
  40-49 
  50-59 
  60+ 
 
 
3. Are you responsible for handling and/or disposing of pharmaceuticals in your 
job duties? 
  Yes 
  No 
 
 
4. How long have you worked in the medical field? 
  Less than 5 yrs 
  6-10 yrs 
  11-20 yrs 
  20+ yrs 
 
 
5. How long have you worked in the Hospice industry? 
  Less than 5 yrs 
  6-10 yrs 
  11-20 yrs 
  20+ yrs 
 
 
6. Have you worked with your local water utility in any of the following ways? 
  Pharmaceutical take-back program 
  Education (about pharmaceuticals in water) 
  Proper pharmaceutical disposal methods 
  No, I have not worked with my local water utility 
  Other - please describe: 
7. Does your organization have a pharmaceutical disposal policy? 
  Yes 
  No 
  Don't Know 
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8. How do you dispose of a patient’s unused pharmaceuticals? 
  Kitty litter & garbage 
  Crush & flush 
  Take-back program 
  Dump into garbage 
  Donation 
  Other - please describe: 
 
9. Have you received any training on how to dispose of unused pharmaceuticals? 
  Yes 
  No 
 Don't know 
 
 
10. Check all types of pharmaceutical disposal training you have received. 
  Video 
  During orientation 
  In field 
  By supervisor 
  Policy manual 
  None 
  Other - please describe: 
 
11. In your opinion, how concerned is your organization regarding proper disposal 
methods of patients’ unused medication? 
  Not concerned at all 
  Not too concerned 
  Somewhat concerned 
  Very concerned 




12. In what area are your patients are primarily located? 
  Urban 





13. What type of wastewater system are your patients are primarily on? 
  Septic system 
  Public sewer 
  Don’t know 
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14. How concerned are your patients and/or their families regarding the drug 
disposal methods of their unused medications? 
  Not concerned at all 
  Not too concerned 
  Somewhat concerned 
  Very concerned 
  Don’t know 
 














Proper methods for 
disposal of patients’ 
unused medications 
    
Potential harm 
from drug disposal 
methods by 
Hospice industry 





    
Impact of 
pharmaceuticals 
to aquatic wildlife 
    
Impact of 
pharmaceuticals 
on water sources 
(lakes & rivers) 
    
 
 
16. Would you be receptive to procedure changes regarding disposal of patients’ 
unused drugs? 
  Yes 
  No 
  Maybe - elaborate on maybe response: 
 
 
  61 
 




Best Management Practices Developed by Authors 
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Pharmaceutical Disposal Fact Sheet Developed by Authors 
 
 
 
